المؤلفون: Hays Arnold, Andrew J. Muir, Alexander J. Thompson, Alex M. DePaoli, Lei Ling, Stephen J. Rossi, Alan Wigg, Elizabeth J. Carey, Martin Weltman, Barbara A. Leggett, Marlyn J. Mayo

المصدر: Hepatology Communications, Vol 2, Iss 9, Pp 1037-1050 (2018)
Hepatology Communications

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Hepatology, business.industry, Placebo-controlled study, Original Articles, Placebo, Gastroenterology, Confidence interval, Transaminase, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Alkaline phosphatase, 030211 gastroenterology & hepatology, Original Article, lcsh:Diseases of the digestive system. Gastroenterology, lcsh:RC799-869, business, Adverse effect

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13cd9eea1f82a315b61231ada76cb876Test
https://doaj.org/article/4cf97fa6121848f28eac1a691058cf71Test

المؤلفون: Stephen H. Caldwell, Saumya Jayakumar, Anna Mae Diehl, G. Mani Subramanian, Ling Han, John G. McHutchison, Zachary Goodman, Nezam H. Afdhal, C. Stephen Djedjos, Eric Lawitz, Parvez S. Mantry, Rohit Loomba, Hays Arnold, Robert P. Myers, Michael Charlton

المصدر: Hepatology. 67:549-559

مصطلحات موضوعية: 0301 basic medicine, Liver injury, medicine.medical_specialty, Pathology, Hepatology, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, medicine.disease, Gastroenterology, Confidence interval, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Fibrosis, Simtuzumab, Liver biopsy, Internal medicine, Nonalcoholic fatty liver disease, medicine, 030211 gastroenterology & hepatology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::09ef89cc8d1de3fd4a69a5fb594a147bTest
https://doi.org/10.1002/hep.29514Test

المؤلفون: Stephen A. Harrison, Dana Oliver, Brent A. Neuschwander-Tetri, Hays Arnold, Sudhanshu Gogia

المصدر: Gut. 57(10)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Body Mass Index, Cohort Studies, Fibrosis, Risk Factors, Internal medicine, Diabetes mellitus, medicine, Humans, Obesity, Aged, Retrospective Studies, Aged, 80 and over, Metabolic Syndrome, Univariate analysis, Missouri, business.industry, Gastroenterology, Retrospective cohort study, Odds ratio, Middle Aged, medicine.disease, Texas, Confidence interval, Surgery, Fatty Liver, Median body, Female, Insulin Resistance, business, Body mass index

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a51b6ff4d25abcbd6b3a2484594c8c4Test
https://pubmed.ncbi.nlm.nih.gov/19834122Test

المؤلفون: Olivier Deckmyn, Frédéric Charlotte, R. Myers, Philippe Mathurin, Hugo Perazzo, Mona Munteanu, An Ngo, Raluca Pais, Valentina Peta, Thierry Poynard, Rohit Loomba, Vlad Ratziu, Yen Ngo

المساهمون: Service d'Hépato-Gastro-Entérologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de Recherche Saint-Antoine (CR Saint-Antoine), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), BioPredictive [Paris], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Gilead Sciences, Inc. [Foster City, CA, USA], Department of Medicine [San Diego], University of California [San Diego] (UC San Diego), University of California-University of California, University of California, The research leading to these results has received funding from the European Community’s Seventh Framework Program (FP7/2007–2013) under grant agreement HEALTHF2–2009–241762 for the project FLIP., The FLIP partners’ consortium Vlad Ratziu, Thierry Poynard: Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Sorbonne University, Paris, France, Jean-Marie Castille, Yen Ngo: Biopredictive SAS, Paris, France, Tania Langon: Alma Consulting Group SAS,Paris, France, Chris Day, Dina Tiniakos: University of Newcastle, Newcastle, UK, Debbie Lawlor: University of Bristol, Bristol, UK, Giulio Marchesini: Universita di Bologna, Bologna, Italy, Fabio Marra: University di Firenze, Firenze, Italy, Elisabetta Bugianesi: Universita degli studi di Torino, Torino, Italy, Stefano Bellentani: Universita di Modena e Reggio Emilia, Modena, Italy, Jean-Francois Dufour: Universit_ e de Berne, Berne, Switzerland, Manuel Romero Gomez: Servicio Andaluz de Salud, Spain, Thorkild Sørensen: Bispebjerg hospital, Region Hovedstaden, Bispebjerg, Dutch, Claudio Tribelli: Fondazione Italiana Fegato-Fonlus, Milano, Italy, Samuele De Minicis: Universita di Ancona, Ancona,Italy, Michael Trauner: Medizinischen Universitaet, Wien, Austria, Claudia Oliveira: University of S~ ao Paulo School of Medicine, S~ ao Paulo, Brazil. The FLIP pathology consortium Pierre Bedossa: Assistance Publique-Hopitaux de Paris, hopital Beaujon, University Paris- Diderot, Paris, France, Alastair D. Burt: School of Medicine, University of Adelaide Adelaide, Australia, Annette S.H. Gouw: Department of Pathology & Medical Biology, University Medical Center Groningen, Groningen, The Netherlands, Carolin Lackner: Institute of Pathology, Medical University of Graz, Graz, Austria, Peter Schirmacher: Institut Fur Pathologie, Universit€ atsklinikum Heidelberg, Heidelberg, Germany, Luigi Terracciano: Institute of Pathology, University Hospital, Basel, Switzerland, DinaTiniakos: Medical School, National and Kapodistrian University of Athens, Greece and Medical School, Newcastle University, Newcastle-upon-Tyne, UK, J. Brain: Medical School, Newcastle University, Newcastle-upon-Tyne, UK, Yvonne Bury: Royal Victoria Infi rmary, Hospitals Foundation Trust, Newcastle upon Tyne, UK, Daniela Cabibi: University of Palermo, Palermo, Italy, Frederic Charlotte: Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie- Salpetriere, Universite university of Torino, Ospedale Molinette, Torino, Italy, Luisa Losi: Modena University Hospital, Modena, Italy, Matteo Montani: Institute of Pathology, University of Bern, Bern, Switzerland, Marı a Jesus Pareja: Hospital Universitario de Valme, Sevilla, Spain, Dominique Wendum: Assistance Publique-Hopitaux de Paris, Hopital St Antoine Sorbonne University, Fritz Wrba: Medical University of Vienna, Vienna, Austria, Marianne Ziol: Assistance Publique-Hôpitaux de Paris, Hopital Jean Verdier, Universite Paris 13, Bobigny, France, Vlad Ratziu: Assistance Publique Hopitaux de Paris, Hopital Pitie Salpetriere, Sorbonne University, Paris,France. The FibroFrance group Thierry Poynard, Vlad Ratziu, Dominique Thabut, Joseph Moussalli, Pascal Lebray, Marika Rudler, Francoise Imbert Bismuth, Frederic Charlotte, Olivier Rosmorduc, Yvon Calmus: Anti- Fibrosis Center, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie-Salpetriere, Sorbonne University, Paris, France, Agnes Hartemann, Sophie Jacqueminet: Diabetes Center, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie-Salpetriere, Sorbonne University, Paris, France, Eric Bruckert, Philippe Giral: Lipid Center, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie-Salpetriere, Sorbonne University, Paris, France, Sylvie Naveau, Gabriel Perlemuter: Alcoholic liver Disease Center, Assistance Publique Hopitaux de Paris, Antoine Beclere Hospital, Clamart, France, Brigitte Varsat: Prevention Centers of Caisse Primaire Assurance Maladie, Paris, France, Anne Mercadier: Transfusion Unit, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie-Salpetriere, Sorbonne University, Paris, France Selonsertib group Study investigators in United States: Manal Abdelmalek, Hays Arnold, Kiran Bambha, Jaideep Behari, Stephen Caldwell, Naga Chalasani, Michael Charlton, James Cooper, Bradley Freilich, Reem Ghalib, Bilal Hameed, Kris V. Kowdley, Michelle Lai, Eric Lawitz, Rohit Loomba, Parvez Mantry, Mary Rinella, Arun Sanyal, Mitchell L. Shiffman, Paul Thuluvath, and Dawn Torres, in Canada : Saumya Jayakumar, and Magdy Elkhashab., European Project: 241762,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,FLIP(2010), Gestionnaire, Hal Sorbonne Université, Fatty liver: Inhibition of Progression - FLIP - - EC:FP7:HEALTH2010-01-01 - 2013-06-30 - 241762 - VALID, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Department of Medicine [Univ California San Diego] (MED - UC San Diego), School of Medicine [Univ California San Diego] (UC San Diego), University of California (UC)-University of California (UC)-University of California [San Diego] (UC San Diego), University of California (UC)-University of California (UC), University of California (UC)

المصدر: European Journal of Gastroenterology & Hepatology
European Journal of Gastroenterology and Hepatology
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2019, 31 (3), pp.393-402. ⟨10.1097/MEG.0000000000001304⟩
European Journal of Gastroenterology & Hepatology, 2019, 31 (3), pp.393-402. ⟨10.1097/MEG.0000000000001304⟩
BASE-Bielefeld Academic Search Engine

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Concordance, Biopsy, SteatoTest, false-positive steatosis test, Gastroenterology, Severity of Illness Index, 03 medical and health sciences, 0302 clinical medicine, Sex Factors, Predictive Value of Tests, Internal medicine, Original Articles: Hepatology, medicine, Prevalence, Blood test, Humans, control group for steatosis test, Prospective cohort study, Retrospective Studies, Hepatology, Receiver operating characteristic, medicine.diagnostic_test, business.industry, Age Factors, Reproducibility of Results, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Retrospective cohort study, Middle Aged, medicine.disease, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Confidence interval, 3. Good health, Fatty Liver, 030220 oncology & carcinogenesis, Predictive value of tests, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, false-negative steatosis test, Feasibility Studies, 030211 gastroenterology & hepatology, Female, Steatosis, business, noninvasive diagnosis, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fecd4f121daac82c063507afd2cd3c37Test
https://pubmed.ncbi.nlm.nih.gov/30516570Test